Download from app store
We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
Philip Schauer MD

Philip Schauer MD

Mary Kay and Terrell Brown/Harris J. Chustz Chair and Professor of Metabolic Surgery, Pennington Biomedical Research Center at Louisiana State University, Baton Rouge, Louisiana

Dr. Philip Schauer is the Mary Kay and Terrell Brown / Harris J. Chustz endowed Professor of Metabolic Surgery at Pennington Biomedical Research Center of Louisiana State University in Baton Rouge, Louisiana. He is Director of the Bariatric and Metabolic Institute at Pennington Biomedical. He is formerly Professor of Surgery at the Cleveland Clinic Lerner College of Medicine.  He is past president of the American Society for Metabolic & Bariatric Surgery (ASMBS). He is former Chair and founder of Obesity Week (2012-present) and Co-Chair of the Diabetes Surgery Summit (2007, 2015, 2019).

Dr. Schauer's clinical interests include obesity, diabetes and metabolic surgery. He has performed more than 8000 operations for severe obesity and diabetes.  His research interests include the pathophysiology of obesity and type 2 diabetes, and outcomes of metabolic surgery.

He has authored more than 400 scientific papers, 60 textbook chapters, and 3 textbooks related to obesity, bariatric/metabolic surgery and gastrointestinal surgery with more than 20,000 citations, highest amongst peers. He is principal investigator of the STAMPEDE trail comparing medical and surgical treatment of diabetes published in New England Journal of Medicine (2012, 2014, 2017) with more than 3500 citations and numerous awards from American Heart Association, American College of Cardiology, NIH and Wall Street Journal.  He has been principal investigator on 3 NIH funded studies evaluating surgical treatment of diabetes and obesity. He is past chairman of the Bariatric Surgery Section of The Obesity Society (TOS). He has been a member of the editorial board of the International Journal of Obesity, Surgery for Obesity and Related Diseases and Obesity Surgery as well as 3 other scientific journals. He has been an invited speaker for more than 200 international lectures on the subject of metabolic surgery. He is founder of the Minimally Invasive Surgery Symposium (MISS) now in its 20th year.  He has trained more than 200 postgraduate surgeons and 100 fellows in advanced laparoscopic and bariatric surgery (3 Presidents of ASMBS). He holds 4 patents for medical devices. He is the recipient of the Cleveland Clinic 2015 Sones Award – highest honor for scientific innovation at the Cleveland Clinic. He is the recipient of the SAGES Pioneer in Surgical Endoscopy Award 2018.


Dr. Schauer reports the following:
  • Current Employer: Pennington Biomedical Research Center
  • Consultancy Agreements: GI Dynamics; Keyron; Persona; Mediflix
  • Ownership Interest: SE Healthcare LLC
  • Research Funding: Ethicon; Medtronic; Pacira; Persona
  • Honoraria: Ethicon; Medtronic; BD Surgical; Gore
  • Scientific Advisor or Membership: SE Healthcare Board of Directors; GI Dynamics ; Keyron; Persona; Mediflix